160 related articles for article (PubMed ID: 30413200)
21. Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States.
Elbasha E; Greaves W; Roth D; Nwankwo C
J Viral Hepat; 2017 Apr; 24(4):268-279. PubMed ID: 27966249
[TBL] [Abstract][Full Text] [Related]
22. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
[TBL] [Abstract][Full Text] [Related]
23. Association of Pulse Wave Velocity With Chronic Kidney Disease Progression and Mortality: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort).
Townsend RR; Anderson AH; Chirinos JA; Feldman HI; Grunwald JE; Nessel L; Roy J; Weir MR; Wright JT; Bansal N; Hsu CY;
Hypertension; 2018 Jun; 71(6):1101-1107. PubMed ID: 29712736
[TBL] [Abstract][Full Text] [Related]
24. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
[TBL] [Abstract][Full Text] [Related]
25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
26. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
[TBL] [Abstract][Full Text] [Related]
27. Corneal Collagen Cross-Linking in the Management of Keratoconus in Canada: A Cost-Effectiveness Analysis.
Leung VC; Pechlivanoglou P; Chew HF; Hatch W
Ophthalmology; 2017 Aug; 124(8):1108-1119. PubMed ID: 28457614
[TBL] [Abstract][Full Text] [Related]
28. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
[TBL] [Abstract][Full Text] [Related]
29. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
[TBL] [Abstract][Full Text] [Related]
30. Cost-Utility Analysis of Apixaban versus Warfarin in Atrial Fibrillation Patients with Chronic Kidney Disease.
Altawalbeh SM; Alshogran OY; Smith KJ
Value Health; 2018 Dec; 21(12):1365-1372. PubMed ID: 30502779
[TBL] [Abstract][Full Text] [Related]
31. Effects of glomerular filtration rate estimating equations derived from different reference methods on staging and long term mortality risks of chronic kidney disease in a Southeast Asian cohort.
Yamwong S; Kitiyakara C; Vathesatogkit P; Saranburut K; Chittamma A; Cheepudomwit S; Vanavanan S; Akrawichien T; Sritara P
Nephrology (Carlton); 2016 Aug; 21(8):678-86. PubMed ID: 26512951
[TBL] [Abstract][Full Text] [Related]
32. Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis.
Zhang Z; Cai L; Wu H; Xu X; Fang W; He X; Wang X; Li X
Front Public Health; 2021; 9():712027. PubMed ID: 34368073
[No Abstract] [Full Text] [Related]
33. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.
Mahmood U; Healy HG; Kark A; Cameron A; Wang Z; Abeysekera R; Hoy WE
BMC Nephrol; 2017 Dec; 18(1):372. PubMed ID: 29282014
[TBL] [Abstract][Full Text] [Related]
34. [Applications of microsimulation model for cost-effectiveness analysis on screening in epidemiology].
Liu QP; Wang JM; Gong C; Gao P; Tang X; Hu Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):931-937. PubMed ID: 35725352
[TBL] [Abstract][Full Text] [Related]
35. A contemporary evaluation of carotid endarterectomy outcomes in patients with chronic kidney disease in the United States.
Patel AR; Dombrovskiy VY; Vogel TR
Vascular; 2017 Oct; 25(5):459-465. PubMed ID: 28181855
[TBL] [Abstract][Full Text] [Related]
36. Cost-Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand.
Vareesangthip K; Deerochanawong C; Thongsuk D; Pojchaijongdee N; Permsuwan U
Adv Ther; 2022 Mar; 39(3):1279-1292. PubMed ID: 35038121
[TBL] [Abstract][Full Text] [Related]
37. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
Ferguson TW; Tangri N; Tan Z; James MT; Lavallee BDA; Chartrand CD; McLeod LL; Dart AB; Rigatto C; Komenda PVJ
Kidney Int; 2017 Jul; 92(1):192-200. PubMed ID: 28433383
[TBL] [Abstract][Full Text] [Related]
38. A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.
Hoerger TJ; Wittenborn JS; Segel JE; Burrows NR; Imai K; Eggers P; Pavkov ME; Jordan R; Hailpern SM; Schoolwerth AC; Williams DE;
Am J Kidney Dis; 2010 Mar; 55(3):452-62. PubMed ID: 20116911
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
Chen PM; Wada T; Chiang CK
Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
[TBL] [Abstract][Full Text] [Related]
40. Optimal timing of coronary angiograms for patients with chronic kidney disease: association between the duration of kidney dysfunction and SYNTAX scores.
Song B; Dai D; Liu S; Zhu Z; Ding F; Zhu J; Zhang R
Ren Fail; 2021 Dec; 43(1):307-312. PubMed ID: 33538236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
